Goldman Sachs Leads $62M Series D Round In Chinese CRO Firm Fountain Medical

This Data Is Locked!

This area is available only to Subscribers.

Fountain Medical, a Chinese clinical-stage contract research organization (CRO) offering one-stop services to pharmaceutical and medical device companies, has raised US$62 million in a series... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?